Urinary tract infections affect 150 million people annually, with E. coli responsible for 80-85% of cases. Discover how carrageenan (sea moss's primary structural polysaccharide) inhibits bacterial adhesion to uroepithelial cells by competitive binding to type 1 fimbriae, how fucoidan's anti-biofilm properties may reduce E. coli virulence factor expression, how sea moss zinc supports mucosal immune defense in the urogenital tract, and how its prebiotic fiber maintains the gut microbiome composition that influences vaginal microbiome health. Critical: sea moss cannot treat an active UTI -- symptomatic urinary infections require antibiotic treatment and physician evaluation; do not delay antibiotics for recurrent UTI.
For the complete science-backed breakdown, including mechanisms, dosing, timing, and safety considerations, read our full guide:
Sea Moss for UTI Prevention: Antimicrobial Mechanisms and Urinary Tract Health
Key topics covered:
- The specific compounds in sea moss relevant to this condition
- Mechanistic pathways (not just anecdotal claims)
- Evidence-based dosing protocols and timing
- Drug interactions and contraindications
- How to integrate with conventional medical care
- What results are realistic and on what timeline

Shop All